文献速递乳房整形与再造

即刻乳房重建可允许及时启动乳房切除术后放疗

Immediate Breast Reconstruction Allows for the Timely Initiation of Postmastectomy Radiation Therapy.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

基于美国国家癌症数据库的回顾性队列研究显示,乳房重建患者启动乳房切除术后放疗的时间较未重建者延长(154天 vs 132天,p<0.001),放疗延迟风险升高(OR 1.25,95%CI 1.188–1.314),但即刻乳房重建组调整后总生存无降低(HR 0.836,95%CI 0.802–0.871,p<0.001)。

要点

  • 乳房重建与放疗启动延迟相关,但延迟幅度有限。
  • 即刻乳房重建未降低调整后总生存。
  • 不同化疗状态下放疗启动影响生存的阈值天数不同。

核心结论

  • 即刻乳房重建与乳房切除术后放疗启动的适度延迟相关,但不影响总生存。

研究设计与样本

  • 使用美国国家癌症数据库的回顾性队列研究,纳入接受乳房切除并接受乳房切除术后放疗的乳腺癌女性。
  • 放疗延迟定义:接受辅助化疗者术后6个月及以上启动,接受新辅助化疗或无化疗者术后12周及以上启动。

主要发现

  • 乳房重建患者放疗启动时间较未重建者延长(154天 vs 132天,p<0.001)。
  • 乳房重建患者放疗延迟风险升高(OR 1.25,95%CI 1.188–1.314)。
  • 其他与放疗延迟相关的因素包括Charlson/Deyo评分增高、新辅助化疗、非私人保险和黑人种族。
  • Cox比例风险模型显示即刻乳房重建组调整后总生存无降低证据(HR 0.836,95%CI 0.802–0.871,p<0.001)。
  • 限制性立方样条分析确定放疗启动开始影响生存的阈值天数:辅助化疗者169天(95%CI 160–190天),新辅助化疗者75天(95%CI 42–90天),无化疗者71天(95%CI 41–90天)。

临床怎么用

  • 即刻乳房重建后应关注放疗启动时间,避免不必要延迟。
  • 对接受新辅助化疗或无化疗者,需更密切监测放疗启动时机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Complications from breast reconstruction may delay postmastectomy radiation therapy and impact breast cancer outcomes. The authors hypothesized that immediate breast reconstruction may be associated with delays in the initiation of radiation, but that this delay would not significantly impact overall patient survival. METHODS: Using the National Cancer Database, the authors identified women with breast cancer who underwent mastectomy and received postmastectomy radiation therapy. Delayed radiation was defined as treatment initiated 6 months or more after surgery in patients who received adjuvant chemotherapy or 12 weeks or more after surgery in patients who received neoadjuvant or no chemotherapy. RESULTS: Women undergoing breast reconstruction had an increased time to postmastectomy radiation therapy, 154 days versus 132 days (p < 0.001), and were more likely to experience a delay in initiating radiation (OR, 1.25; 95 percent CI, 1.188 to 1.314). Other factors associated with delayed radiation included increased Charlson/Deyo scores, neoadjuvant chemotherapy, nonprivate insurance, and black race. Cox proportional hazards models revealed no evidence of a reduced adjusted overall survival in the immediate breast reconstruction group (hazard ratio, 0.836; 95 percent CI, 0.802 to 0.871; p < 0.001). Restricted cubic spline analysis identified the threshold number of days at which the start of radiation began to impact survival at 169 days (95 percent CI, 160 to 190 days), 75 days (95 percent CI, 42 to 90 days), and 71 days (95 percent CI, 41 to 90 days) in patients undergoing adjuvant, neoadjuvant, and no chemotherapy, respectively. CONCLUSION: Immediate breast reconstruction is associated with a modest delay in initiating postmastectomy radiation therapy but does not impact overall survival. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Shammas RL, Ren Y, Thomas SM, et al. Immediate Breast Reconstruction Allows for the Timely Initiation of Postmastectomy Radiation Therapy. Plast Reconstr Surg. 2019. PMID: 31460998. doi:10.1097/PRS.0000000000005899

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。